|
|
 |
| SLEEPING AIDS |
Insomnia occurs in more thatn 50% of the population at some time. It tends to occur more frequently with advancing age and is more prevalent to women than in men. Insomnia is the inability to obtain sleep of sufficient length or quality to produce refreshment upon awakening. It can manifest as difficulty falling asleep, difficulty remaining asleep, early morning awakening, or sleep that it not restorative.
Continued insomnia results in reduced productivity, increased risk of accidents, decreased productive behavior and increased risk of excessive alcohol (or other depressant) use. (Use of alcohol to induce sleep is counterproductive because even though it may induce sleep, it interferes with the stages of deep sleep that are important for refreshment and regenerative processes.) |
|
| Rozerem |
 |
|
Rozerem is the first and only prescription sleep medication that has shown no evidence of abuse and dependence and, as a result, has not been designated as a controlled substance by the DEA. With the exception of Rozerem, all other prescription medications indicated for insomnia are classified as Schedule IV controlled substances by the DEA. Additionally, Rozerem is the first prescription insomnia medication with a new therapeutic mechanism of action in 35 years. |
 |
|
|
|
|
